UCB’s Neupro Manufacturing Problems Hold Up Approval For Advanced Parkinson’s Disease
UCB must resolve the issue of drug crystal formation in the Neupro patch before it can be approved for two supplemental indications.
UCB must resolve the issue of drug crystal formation in the Neupro patch before it can be approved for two supplemental indications.